Stage IV Hypopharyngeal Squamous Cell Carcinoma AJCC v7

6 clinical trials · Condition

Record	Firm	Date
Pembrolizumab & Cabozantinib in Patients With Head and Neck Squamous Cell Cancer (NCT03468218)	Emory University	2018-09-18
Testing the Addition of M6620 (VX-970, Berzosertib) to Usual Chemotherapy and Radiation for Head and Neck Cancer (NCT02567422)	National Cancer Institute (NCI)	2017-04-17
Testing Docetaxel-Cetuximab or the Addition of an Immunotherapy Drug, Atezolizumab, to the Usual Chemotherapy and Radiation Therapy in High-Risk Head and Neck Cancer (NCT01810913)	National Cancer Institute (NCI)	2013-03-22
Lenalidomide and Cetuximab in Treating Patients With Advanced Colorectal Cancer or Head and Neck Cancer (NCT01254617)	National Cancer Institute (NCI)	2011-02-10
Combination Chemotherapy With or Without Erlotinib Hydrochloride in Treating Patients With Metastatic or Recurrent Squamous Cell Carcinoma of the Head and Neck (NCT01064479)	M.D. Anderson Cancer Center	2010-02-05
Chemotherapy With or Without Bevacizumab in Treating Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma (NCT00588770)	National Cancer Institute (NCI)	2008-08-08

Every clearance here is in the API, with alerts when new ones post.